Affymetrix, Inc.

Other

Winfield Laboratories, Inc.

Bayer Corporation

Bayer Pharmaceuticals Corporation

Ennis-flint, Inc.

Christopher Allen Davies

Charles Garrett Miyada

John E Blume

Alan J Williams

Shivani Nautiyal

Yanxiang Cao

Richard Bonar Davies

Eric B Schell

Gangwu Mei

Steve Roczniak

Douglas D Dolinar

Kevin Goforth

Bruce W Gouldey

Dadong Chen

Jeanette Pruzan Schmidt

Gary W Cummings

Kathy Delaria

Brant Wong

A bulk loader system is disclosed that may include a conveyor unit in connection with a fuel-powered engine powering a hydraulic motor. The hydraulic motor may be used to operate the conveyor unit. The system may be configured to function while being mounted on a bed of a truck or be operated as a stand-alone unit. The unit may be sized such that an operator can stand on the deck of the truck along with the unit. The fuel-hydraulic powered motor can enable the conveyor unit to operate at variable speeds. The conveyor unit can be adjustable to facilitate controlling the direction of the material being transported via the conveyor. Some embodiments can include operating the hydraulics of the motor from the Power Take-Off ('PTO') of the truck. Some embodiments can facilitate operation of the system in a hot or other harsh environment.

Bulk loader system for thermoplastic pellets

Arrays for genome-wide analysis of methylation are disclosed. In a preferred aspect arrays comprising a plurality of probes complementary to a plurality of identified CpG islands in the human, mouse and rat genome are disclosed. The arrays may be used to detect methylation within CpG islands in samples from human, mouse and rat genomes.

Analysis of methylation using nucleic acid arrays

A mechanical button that is adjacent to a touch screen that allows for the forceful activation of a computer touch screen by a user without such force of activation of the disclosed button by the user causing damage to the touch screen. This disclosed button is comprised of at least 2 sections that can be caused to compress relative to one another along their common linier axis and the disclosed button is supported by a structure other than the face of the touch screen. The disclosed button, unlike a lighted area on a flat touch screen, provides the user with tactile feedback when the button is activated and the disclosed button further creates a three dimensional visual target that facilitates the user's ability to see the button in their peripheral field of vision, rather than seeing only a lighted area on a flat touch screen.

Mechanical button that activates a computer touch screen without causing damage to the touch screen

Methods and systems for the determination of a collection of relevant single nucleotide polymorphisms (SNP) probe compatible insertion/deletion probes across a genome to determine probes that can detect a variety of insertions and deletions.

Systems and methods for probe design to detect the presence of simple and complex indels

A seal formed of laminated films adhered to a peel strip. The seal includes a target area free of adhesive, and adhesive surrounding the target area. The seal is formed so that the target area is visually distinguished from the surrounding adhesive to facilitate accurate placement of the seal on a medical container by a user. The use of a large adhesive dot pattern enhances the peripheral edge of each adhesive dot to provide a prominent and visual lattice. The prominent and visual lattice distinguishes the adhesive areas of the seal from the non-adhesive areas. The lattice boundary surrounding each adhesive dot is still prominent and visible when a clear and transparent adhesive is applied to selected surfaces of the seal.

Tamper evident seal with visible adhesive dot pattern

A seal formed of laminated films adhered to a peel strip. The seal includes a target area free of adhesive, and adhesive surrounding the target area. The seal is formed so that the target area is visually distinguished from the surrounding adhesive to facilitate placement of the seal on a medical container by a user. The use of a colored adhesive, reflectivity of the adhesive, a colored laminate, or a colored target background can be utilized to make the target area visually different from the surrounding adhesive.

Tamper evident seal for a medical container

Arrays for genome-wide analysis of methylation are disclosed. IN a preferred aspect arrays comprising a plurality of probes complementary to a plurality of identified CpG islands in the human, mouse and rat genome are disclosed. The arrays may be used to detect methylation within cpG islands in samples from human, mouse and rat genomes.

A wearable device to comfortably and ergonomically transfer substantially all of the weight of a heavy protective garment from a wearer's shoulders, neck and back to the wearer's waist, in a manner that does not interfere with the normal and necessary movement and range of motion of the wearer. The device transfers the weight of the protective garment from the shoulder area of the wearer to a belt at the waist/hip area of the wearer via a vertical support member(s) that incorporate(s) articulating and adjustable elements which permit the device to accommodate the natural movement of the wearer's body at the waist, back, neck and shoulders while transferring the weight of the protective garment to the waist/hip area of the wearer. The subject device may also be incorporated into or made part of a protective garment.

Waist belt having articulated shoulder straps

BTL.010 is a novel human serine proteinase inhibitor of the Kunitz family that exhibits greater potency towards neutral serine proteinases, particularly leukocyte elastase and proteinase 3 than towards trypsin-like proteinases. BTL.010, or variants thereof, may be employed as therapeutics in diseases such as emphysema, idiopathic pulmonary fibrosis, adult respiratory distress syndrome, cystic fibrosis, rheumatoid arthritis, organ failure, and glomerulonephritis in which uncontrolled proteolysis due to neutral serine proteinase activity results in tissue damage.

Polynucleotide molecules encoding proteins having proteinase inhibitor activity

BTL.009 is a novel human serine proteinase inhibitor of the Kunitz family that exhibits greater potency towards neutral serine proteinases, particularly leukocyte elastase, and chymotrypsin than towards trypsin-like proteinases. BTL.009, or variants thereof, may be employed as therapeutics in diseases such as emphysema, idiopathic pulmonary fibrosis, adult respiratory distress syndrome, cystic fibrosis, rheumatoid arthritis, organ failure, and glomerulonephritis in which uncontrolled proteolysis due to neutral serine proteinase activity results in tissue damage.

Protein having proteinase inhibitor activity

BTL.010 is a novel human serine proteinase inhibitor of the Kunitz family that exhibits greater potency towards neutral serine proteinases, particularly leukocyte elastase-, and proteinase 3, than towards trypsin-like proteinases. BTL.010, or variants thereof, may be employed as therapeutics in diseases such as emphysema, idiopathic pulmonary fibrosis, adult respiratory distress syndrome, cystic fibrosis, rheumatoid arthritis, organ failure, and glomerulonephritis in which uncontrolled proteolysis due to neutral serine proteinase activity results in tissue damage.

Growing community of inventors

Sandy, UT, United States of America

Christopher Allen Davies